Several lines of evidence have shown that MTTP polymorphisms may modulate the lipid homeostasis and may eventually lead to a high risk for NAFLD if such function is compromised because of genetic variation. This evidence concerns the gene MT-TP and metabolic dysfunction-associated steatotic liver disease.